Verity Asset Management, Inc. Bristol Myers Squibb CO Transaction History
Verity Asset Management, Inc.
- $255 Billion
- Q2 2024
A detailed history of Verity Asset Management, Inc. transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Verity Asset Management, Inc. holds 15,648 shares of BMY stock, worth $774,419. This represents 0.25% of its overall portfolio holdings.
Number of Shares
15,648
Previous 6,212
151.9%
Holding current value
$774,419
Previous $337 Million
92.91%
% of portfolio
0.25%
Previous 0.19%
Shares
10 transactions
Others Institutions Holding BMY
# of Institutions
2,400Shares Held
1.5BCall Options Held
29.7MPut Options Held
32.2M-
Vanguard Group Inc Valley Forge, PA187MShares$9.23 Billion0.15% of portfolio
-
Black Rock Inc. New York, NY159MShares$7.85 Billion0.15% of portfolio
-
State Street Corp Boston, MA91.4MShares$4.53 Billion0.17% of portfolio
-
Jpmorgan Chase & CO New York, NY74.6MShares$3.69 Billion0.27% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA59.1MShares$2.92 Billion0.47% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $105B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...